These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 2242999)
21. Effects of intravitreal dispase on vitreoretinal interface in rabbits. Zhu D; Chen H; Xu X Curr Eye Res; 2006 Nov; 31(11):935-46. PubMed ID: 17114119 [TBL] [Abstract][Full Text] [Related]
22. Retinal function and histologic changes following intravitreal injection of indocyanine green in a rabbit model. Chao AN; Chen SN; Kuo YH J Ocul Pharmacol Ther; 2004 Oct; 20(5):450-9. PubMed ID: 15650520 [TBL] [Abstract][Full Text] [Related]
23. Retinal toxicity of intravitreal kenalog in albino rabbits. Lang Y; Zemel E; Miller B; Perlman I Retina; 2007; 27(6):778-88. PubMed ID: 17621190 [TBL] [Abstract][Full Text] [Related]
25. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Schuettauf F; Haritoglou C; May CA; Rejdak R; Mankowska A; Freyer W; Eibl K; Zrenner E; Kampik A; Thaler S Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3573-8. PubMed ID: 16877431 [TBL] [Abstract][Full Text] [Related]
26. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Rodrigues EB; Penha FM; Farah ME; de Paula Fiod Costa E; Maia M; Dib E; Bottós J; Freymuller E; Furlani B; Meyer CH; Magalhães O; Lima-Filho AA; Safatle A Retina; 2009 Apr; 29(4):497-510. PubMed ID: 19174713 [TBL] [Abstract][Full Text] [Related]
27. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits. Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418 [TBL] [Abstract][Full Text] [Related]
28. Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Penha FM; Maia M; Eid Farah M; Príncipe AH; Freymüller EH; Maia A; Magalhães O; Smith RL Ophthalmology; 2007 May; 114(5):899-908. PubMed ID: 17292475 [TBL] [Abstract][Full Text] [Related]
29. Reliability of intravitreal nepafenac in rabbits. Afrashi F; Hashas AS; Shahbazov C; Arici M; Yikilmaz MS; Deveci R; Karacali S; Sahar U J Ocul Pharmacol Ther; 2015 Feb; 31(1):43-50. PubMed ID: 25285465 [TBL] [Abstract][Full Text] [Related]
30. Intravitreal toxicity of garenoxacin. Esfahani MR; Kazi AA; Peyman GA; Dellacroce JT; Aydin E Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675 [TBL] [Abstract][Full Text] [Related]
31. Safety threshold of intravitreal activated protein-C. Nishida K; Kamei M; Du ZJ; Xie P; Yamamoto T; Suzuki M; Sakaguchi H; Nishida K Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):833-8. PubMed ID: 21107855 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391 [TBL] [Abstract][Full Text] [Related]
33. Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Eckardt C; Nicolai U; Winter M; Knop E Retina; 1991; 11(4):375-84. PubMed ID: 1813952 [TBL] [Abstract][Full Text] [Related]
34. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Unal M; Peyman GA Retina; 2000; 20(1):69-75. PubMed ID: 10696751 [TBL] [Abstract][Full Text] [Related]
35. Effects of intravitreal indocyanine green injection in rabbits. Maia M; Margalit E; Lakhanpal R; Tso MO; Grebe R; Torres G; Au Eong KG; Farah ME; Fujii GY; Weiland J; de Juan E; D'Anna SA; Humayun MS Retina; 2004 Feb; 24(1):69-79. PubMed ID: 15076947 [TBL] [Abstract][Full Text] [Related]
36. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158 [TBL] [Abstract][Full Text] [Related]
37. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Takano A; Hirata A; Ogasawara K; Sagara N; Inomata Y; Kawaji T; Tanihara H Invest Ophthalmol Vis Sci; 2006 May; 47(5):2075-9. PubMed ID: 16639018 [TBL] [Abstract][Full Text] [Related]
38. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Antoszyk AN; Gottlieb JL; Machemer R; Hatchell DL Graefes Arch Clin Exp Ophthalmol; 1993; 231(1):34-40. PubMed ID: 8428678 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal toxicity of high-dose etanercept. Kivilcim M; Peyman GA; Kazi AA; Dellacroce J; Ghobrial RN; Monzano R J Ocul Pharmacol Ther; 2007 Feb; 23(1):57-62. PubMed ID: 17341152 [TBL] [Abstract][Full Text] [Related]